Segment disclosures

Company overview

바이오비쥬

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 15 retained observations 10 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Consolidated

Consolidated And Separate Financial Statements

Source dimensions ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-309875617427 KRW20260812Open filing evidence
2026-01-01 – 2026-06-3017890264980 KRW20260812Open filing evidence
2026-01-01 – 2026-03-318014647553 KRW20260514Open filing evidence
2025-01-01 – 2025-12-3128490907891 KRW20260323Open filing evidence
2025-07-01 – 2025-09-306640460473 KRW20251114Open filing evidence
2025-01-01 – 2025-09-3024463716547 KRW20251114Open filing evidence
2025-04-01 – 2025-06-306237068317 KRW20260812Open filing evidence
2025-01-01 – 2025-06-3017823256074 KRW20260812Open filing evidence
2025-01-01 – 2025-03-3111586187757 KRW20260514Open filing evidence
2024-01-01 – 2024-12-3129633293971 KRW20260323Open filing evidence
2024-07-01 – 2024-09-306935000757 KRW20251114Open filing evidence
2024-01-01 – 2024-09-3020390579281 KRW20251114Open filing evidence
2024-04-01 – 2024-06-307052355209 KRW20250814Open filing evidence
2024-01-01 – 2024-06-3013455578524 KRW20250814Open filing evidence
2023-01-01 – 2023-12-3117130294335 KRW20260323Open filing evidence